Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. NCPD information and select publications <a href="https://www.researchtopractice.com/ONU2024/BispecificsLymphoma/1" rel="noopener noreferrer" target="_blank">here.</a>

Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma. NCPD information and select publications here.

Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.&nbsp;NCPD information and select publications <a href="https://www.researchtopractice.com/ONU2024/BispecificsLymphoma/1" rel="noopener noreferrer">here.</a>

Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1

Medical oncologist Dr Neil Love interviews oncology experts. Free NCPD credit hours are available.

Share Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1

Sign up to save your podcasts

Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1

Special 2-Part Edition for Oncology Nurses: Bispecific Antibodies in Lymphoma — Part 1